Comments
Loading...

Acumen Pharmaceuticals Inc Earnings Estimates

ABOSNASDAQ
$2.41
-0.1-3.98%
Last update: Feb 17, 11:59 AM

Acumen Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:ABOS

Acumen Pharmaceuticals (ABOS) is scheduled to report Q4 earnings on March 26, 2026. Analysts estimate EPS of $-0.53 and quarterly revenue of N/A.

In the most recent quarter (Q3), Acumen Pharmaceuticals reported EPS of $-0.44, beating estimates of $-0.66 by 0.33%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Over the last 4 quarters, Acumen Pharmaceuticals has averaged an EPS surprise of 0.35% and a revenue surprise of 0.00%.

Earnings Date
Mar 26
EPS Estimate
$-0.530
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
–

Acumen Pharmaceuticals Earnings History

Analyze the earnings history of Acumen Pharmaceuticals using advanced sorting and filters.

Get Alert
ABOSAcumen PharmaceuticalsQ1-$0.48-$0.53——$0.00———05/12/2026Get Alert
ABOSAcumen PharmaceuticalsQ4-$0.62-$0.53——$0.00———03/26/2026Get Alert
ABOSAcumen PharmaceuticalsQ3-$0.50-$0.66-$0.4433.33%$0.00—$0.00—11/12/2025Get Alert
ABOSAcumen PharmaceuticalsQ2-$0.34-$0.53-$0.68-28.30%$0.00—$0.00—08/12/2025Get Alert
ABOSAcumen PharmaceuticalsQ1-$0.25-$0.55-$0.4812.73%$0.00—$0.00—05/13/2025Get Alert
ABOSAcumen PharmaceuticalsQ4-$0.29-$0.37-$0.62-67.57%$0.00—$0.00—03/27/2025Get Alert
ABOSAcumen PharmaceuticalsQ3-$0.24-$0.36-$0.50-38.89%$0.00—$0.00—11/12/2024Get Alert
ABOSAcumen PharmaceuticalsQ2-$0.28-$0.28-$0.34-21.43%$0.00—$0.00—08/13/2024Get Alert
ABOSAcumen PharmaceuticalsQ1-$0.28-$0.26-$0.253.85%$0.00—$0.00—05/14/2024Get Alert
ABOSAcumen PharmaceuticalsQ4-$0.32-$0.26-$0.29-11.54%$0.00—$0.00—03/26/2024Get Alert
ABOSAcumen PharmaceuticalsQ3-$0.26-$0.27-$0.2411.11%$0.00—$0.00—11/13/2023Get Alert
ABOSAcumen PharmaceuticalsQ2-$0.25-$0.36-$0.2822.22%$0.00—$0.00—08/08/2023Get Alert
ABOSAcumen PharmaceuticalsQ1-$0.23-$0.35-$0.2820.00%$0.00—$0.00—05/09/2023Get Alert
ABOSAcumen PharmaceuticalsQ4-$0.21-$0.25-$0.32-28.00%$0.00—$0.00—03/27/2023Get Alert
ABOSAcumen PharmaceuticalsQ3-$0.10-$0.23-$0.26-13.04%$0.00—$0.00—11/14/2022Get Alert
ABOSAcumen PharmaceuticalsQ2-$7.91-$0.24-$0.25-4.17%$0.00—$0.00—08/15/2022Get Alert
ABOSAcumen PharmaceuticalsQ1-$64.41-$0.17-$0.23-35.29%$0.00—$0.00—05/16/2022Get Alert
ABOSAcumen PharmaceuticalsQ4—-$0.14-$0.21-50.00%——$0.00—03/28/2022Get Alert
ABOSAcumen PharmaceuticalsQ3-$5.94-$0.17-$0.1041.18%$730.00K—$0.00—11/15/2021Get Alert
ABOSAcumen PharmaceuticalsQ2-$4.86-$4.56-$7.91-73.46%$151.00K—$0.00—08/16/2021Get Alert

Acumen Pharmaceuticals (ABOS) Earnings Per Share

The chart below shows Acumen Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q32025-11-12$-0.44$-0.6633.3 %
Q22025-08-12$-0.68$-0.53-28.3 %
Q12025-05-13$-0.48$-0.5512.7 %
Q42025-03-27$-0.62$-0.37-67.6 %

Acumen Pharmaceuticals (ABOS) Revenue

The chart below shows Acumen Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.

FAQ

Q

When is Acumen Pharmaceuticals (NASDAQ:ABOS) reporting earnings?

A

Acumen Pharmaceuticals (ABOS) is scheduled to report earnings on May 12, 2026. The last reported earnings were for reported on November 12, 2025 for Q3.

Q

What were the latest earnings per share (EPS) for Acumen Pharmaceuticals (NASDAQ:ABOS)?

A

The Actual EPS was $-0.44, which beat the estimate of $-0.66.

Q

What were Acumen Pharmaceuticals’s (NASDAQ:ABOS) revenues?

A

The Actual Revenue was $0.00, which hit the estimate of $0.00.